A5032043038- Lung Cancer Treatments and Mutations
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Enhanced Recovery After Surgery
- Gastroesophageal reflux and treatments
- Lung Cancer Diagnosis and Treatment
- Monoclonal and Polyclonal Antibodies Research
- Anesthesia and Sedative Agents
- Chronic Myeloid Leukemia Treatments
- Gastric Cancer Management and Outcomes
- Anesthesia and Neurotoxicity Research
- Galectins and Cancer Biology
- Chronic Lymphocytic Leukemia Research
- Cell Adhesion Molecules Research
- Melanoma and MAPK Pathways
- Mitochondrial Function and Pathology
- Esophageal and GI Pathology
- Cardiac, Anesthesia and Surgical Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Adrenal and Paraganglionic Tumors
- Cancer, Hypoxia, and Metabolism
- Cancer therapeutics and mechanisms
- Neuroscience and Neuropharmacology Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Lymphoma Diagnosis and Treatment
Zunyi Medical University
2023-2024
Southern Medical University Shenzhen Hospital
2024
Boston University
2018
Dana-Farber Cancer Institute
2006-2018
Peking University Cancer Hospital
2009-2016
Peking University
2009-2016
Harvard University
1993-2015
AstraZeneca (United Kingdom)
2009
National Cancer Center
2009
Antwerp University Hospital
2009
CRA8003 The full, final text of this abstract will be available in Part II the 2009 ASCO Annual Meeting Proceedings, distributed onsite at on May 30, 2009, and as a supplement to June 20, issue Journal Clinical Oncology. [Table: see text]
CRA8003 Background: Vandetanib is a once-daily oral inhibitor of VEGFR, EGFR and RET signaling. Addition vandetanib to docetaxel (doc) prolonged progression-free survival (PFS) in randomized phase II study patients (pts) with previously treated NSCLC (Heymach et al, JCO, 2007). Methods: The primary objective was determine whether 100 mg/day + doc 75 mg/m 2 every 21 days (max 6 cycles) PFS vs placebo doc. Secondary endpoints included overall survival, response rate (ORR), time deterioration...
Adrenal tumors are common, but adrenocortical carcinomas (ACCs) a rare and challenging form of cancer to diagnose manage.This study aimed explore the critical role mitochondrial quality in maintaining cellular function implications abnormal expression metabolism-related proteins observed ACC patients. We focused on identifying connection between development at molecular genomic levels. compared quality-related genes (MQRGs) across subtypes using overall survival (OS) disease-free (DFS) as...
<title>Abstract</title> <bold>Background:</bold> Perioperative reflux aspiration presents a grave concern during sedation or general anesthesia, particularly when solid gastric contents prompt acute upper respiratory obstruction, potentially resulting in fatal consequences for patients. Currently, there are limited means promptly assessing clinical settings. Therefore, this study examined the efficacy of ultrasound assessment contents, offering rapid and non-invasive approach early detection...
Introduction Melanoma is the most aggressive skin cancer with a poor prognosis in advanced stages. Available treatments for melanoma are unsatisfactory, because rapidly lead to an acquired resistance majority of cases. Therefore, there urgent need identify novel possible targets involved growth. ERK5/BMK1 member Mitogen-Activated Protein Kinases (MAPK) family and regulates cell functions critical tumour development. Indeed, several studies reported direct involvement ERK5 types including...